Gubra

Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Boehringer Ingelheim
Gubra
clinical trials
BI 3034701
obesity
Boehringer Ingelheim, Gubra to validate new Peptides for obesity
Pharmaceutical Business Review
Tue, 03/2/21 - 10:47 am
Boehringer Ingelheim
Gubra
peptides
obesity
Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Pharmaceutical Business Review
Thu, 05/30/19 - 10:05 am
obesity
peptide poly-agonists
Boehringer Ingelheim
Gubra